Covaxin phase 3 data shows 77.8% efficacy: Lancet{br} https://ift.tt/eA8V8J

A week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, a prestigious medical journal Lancet has stated that the phase 3 data of India’s first indigenously developed vaccine demonstrates 77.8% efficacy against symptomatic Covid-19. Its efficacy data also demonstrates 70.8% protection against all variants of SARS-CoV-2.

from Times of India https://ift.tt/30aDSMa

Comments

Popular posts from this blog

1st gang rape conviction in Muzaffarnagar riots: 2 sentenced to 20 years’ jail{br} https://ift.tt/2fivOAg

IPL: Shardul's fiery spell, Pooran's blitzkrieg propel LSG to win{br} https://ift.tt/VSAIYdq